IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BELLUCCI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.249
EU - Europa 3.370
AS - Asia 1.079
SA - Sud America 12
OC - Oceania 10
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.227
PL - Polonia 1.591
CN - Cina 705
UA - Ucraina 554
IT - Italia 402
DE - Germania 286
HK - Hong Kong 171
FI - Finlandia 154
GB - Regno Unito 109
IE - Irlanda 107
FR - Francia 97
IN - India 74
VN - Vietnam 66
BE - Belgio 24
CA - Canada 22
SE - Svezia 21
SG - Singapore 21
TR - Turchia 14
AU - Australia 10
KR - Corea 9
BR - Brasile 7
NL - Olanda 6
RU - Federazione Russa 6
EU - Europa 5
IR - Iran 5
IL - Israele 4
EG - Egitto 3
GR - Grecia 3
JP - Giappone 3
MU - Mauritius 3
BO - Bolivia 2
CL - Cile 2
EE - Estonia 2
JO - Giordania 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
GE - Georgia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TN - Tunisia 1
Totale 8.733
Salva come PNG Salva come JPEG
Città #
Warsaw 1.591
Fairfield 561
Woodbridge 427
Jacksonville 421
Chandler 292
Ashburn 279
Dearborn 270
Cambridge 245
Houston 240
Seattle 213
Ann Arbor 207
Wilmington 199
Brescia 194
Princeton 192
Hong Kong 170
Nanjing 142
Beijing 123
Dublin 106
New York 97
Helsinki 96
Dong Ket 66
Des Moines 50
Jinan 48
Nanchang 47
Changsha 40
Hebei 40
Shenyang 38
Pune 36
Milan 33
San Diego 30
Tianjin 27
Brussels 23
Kunming 23
Shanghai 23
Ningbo 17
Jiaxing 16
Taizhou 16
Toronto 15
London 14
San Francisco 14
San Giuliano Milanese 13
Zhengzhou 12
Hangzhou 11
Hefei 11
Lanzhou 11
Los Angeles 11
Rome 11
Guangzhou 10
Lancaster 10
Verona 10
Boardman 9
San Donà Di Piave 9
Kocaeli 8
Lappeenranta 8
Taiyuan 8
Cattolica 7
Fuzhou 6
Orange 6
Pavia 6
Ardabil 5
Canberra 5
Haikou 5
Kilburn 5
Napoli 5
Oxford 5
San Cesareo 5
San Mateo 5
Augusta 4
Changchun 4
Fulda 4
Melbourne 4
Norwalk 4
Padova 4
Phoenix 4
Providence 4
Redmond 4
Bergamo 3
Bologna 3
Cairo 3
Chions 3
Kafr Manda 3
Leawood 3
Monmouth Junction 3
Ottawa 3
Singapore 3
São Paulo 3
Ulsan 3
Xian 3
Amman 2
Campo San Martino 2
Chicago 2
Cornate d'Adda 2
Florence 2
Fremont 2
Germering 2
Hounslow 2
Indiana 2
Mainz 2
Mineola 2
Paris 2
Totale 6.994
Salva come PNG Salva come JPEG
Nome #
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 268
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 249
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 244
Anionic liposomes for siRNA delivery to primary neuronal cells: evaluation of Alpha synuclein knockdown efficacy 236
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 226
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 224
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 217
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 214
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 211
INDUCTION OF INFLAMMATORY MEDIATORS AND MICROGLIAL ACTIVATION IN MICE TRANSGENIC FOR MUTANT P301S TAU PROTEIN 204
Living in promiscuity: The multiple partners of alpha-synuclein at the synapse in physiology and pathology 176
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 168
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 156
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 150
Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells 139
Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases 134
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 133
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 133
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 129
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy 120
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 118
DIFFERENTIAL ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE SIGNALLING PATHWAYS IN THE HIPPOCAMPUS OF CRND8 TRANSGENIC MOUSE, A MODEL OF ALZHEIMER'S DISEASE 117
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 113
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 111
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature 108
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 108
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 107
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. 104
Synapsin III alterations in Parkinson's disease 104
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 103
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 102
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 102
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 100
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 99
EFFECT OF SUBCHRONIC ADMINISTRATION OF METRIFONATE, RIVASTIGMINE AND DONEPEZIL ON BRAIN ACETYLCHOLINE IN AGED F344 RATS 95
CHOLINERGIC DYSFUNCTION, NEURONAL DAMAGE AND AXONAL LOSS IN TGCRND8 MICE 94
COMBINED TREATMENT WITH ATORVASTATIN AND MINOCYCLINE SUPPRESSES SEVERITY OF EAE 93
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 91
ABNORMAL PROCESSING OF TAU IN THE BRAIN OF AGED TGCRND8 MICE 90
Presence of Reactive Microglia and Neuroinflammatory Mediators in a Case of Frontotemporal Dementia with P301S Mutation. 87
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 85
ALPHA-SYNUCLEIN MODULATES SYNAPSIN III IN NIGROSTRIATAL DOPAMINERGIC NEURONS: IMPLICATIONS FOR PARKINSON'S DISEASE 75
Parkinson's disease: from synaptic loss to connectome dysfunction 75
Study of alpha-synuclein fibrillation: State of the art and expectations 75
Alpha-synuclein modulates the localization, expression and function of NR2B-containing NMDA receptors: implications in the pathogenesis of Parkinson's disease 73
BETA-AMYLOID INFLAMMATION AND CHOLINERGIC HYPOFUNCTION IN THE RAT BRAIN IN VIVO: INVOLVEMENT OF P38MAPK PATHWAY 72
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 71
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 70
PGRN gene silencing in primary neuronal cultures: a model of FTLD-U 70
Synapsin III Alteration in Parkinson's disease 69
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system 68
Synapsin III Alteration in Parkinson's disease 67
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 66
NF-κB unbalance and dysfunction in acute and age-related neurodegenerative disease 66
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 65
Effects of rofecoxib treatment on brain inflammatory reaction and cholinergic function in beta-(1-42) injected rats into the nucleus basalis 64
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 64
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease 64
The good and bad of therapeutic strategies that directly target α-synuclein 64
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 63
Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson’s disease 62
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 62
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 61
Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET-Based Assay of Synapsin III Binding 61
Alpha-synuclein and NMDA receptors: a novel postsynaptic couple playing a pivotal role in the regulation of the functional activity of nigral dopaminergic neurons 59
In vivo effects of NSAIDs on amyloid beta(1-42)-induced brain neurotoxicity 59
Novel perspectives for Parkinson’s disease therapy: insights from the latest advances in disease pathophysiology, diagnostic and experimental tools and molecular targets 59
Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. 56
Redistribution of DAT/alpha-synuclein complexes visualized "in situ" by proximity ligation assay in a transgenic mouse model of Parkinson's disease 56
Non-steroid antiinflammatory agents (nsaids): are they a valid approach to Alzheimer’s disease prevention? 55
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 55
. Alpha-synuclein is a crucial mediator of mitochondrial fusion and functions 54
Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease 53
Targeting α-Synuclein-Related Synaptic Pathology: Novel Clues for Parkinson’s Disease Therapy 53
Ex vivo characterization of progranulin gene silencing in primary neuronal cultures to study the biological basis of FTLD-U 53
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 53
EXPERIMENTAL BRAIN INFLAMMATION AND NEURODEGENERATION AS MODEL OF ALZHEIMER'S DISEASE: PROTECTIVE EFFECTS OF SELECTIVE COX-2 INHIBITORS 52
Effects of novel NSAIDs on brain inflammation and release of neurotrasmitters in animal models of neurodegeneration 52
Induction of the Unfolded Protein Response by alpha-synuclein in experimental models of Parkinson's disease 51
NSAIDs in animal models of Alzheimer's disease 51
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 50
NSAIDs in animal models of Alzheimer’s Disease 50
Neuroprotective epi-drugs quench the inflammatory response and microglial/macrophage activation in a mouse model of permanent brain ischemia 50
NSAIDs in Animal Models of Alzheimer's disease 49
THE SELECTIVE CYCLOOXIGENASE-2 INHIBITOR ROFECOXIB SUPPRESSES BRAIN INFLAMMATION AND PROTECTS CHOLINERGIC NEURONS FROM EXCITOTOXIC DEGENERATION IN VIVO 47
Nuovi Aspetti di Fisiopatologia del DLB e PDD 45
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 45
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 45
Alpha-synuclein absence affected mitochondrial fusion and functions 44
COMPARISON BETEWEEN FLURBIPROFEN AND ITS NITRIC OXIDE-RELEASING DERIVATIVES HCT-1026 AND NCX-2216 ON ABETA(1-42)-INDUCED BRAIN INFLAMMATION AND NEURONAL DAMAGE IN THE RAT 43
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution 43
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction 31
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 29
The association between α-synuclein and α-tubulin in brain synapses 28
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model 27
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 25
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease 24
NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients 23
ANALOGHI STRUTTURALI DEL METILFENIDATO COME AGENTI DISEASE-MODIFYING DELLA MALATTIA DI PARKINSON 22
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy? 16
Totale 9.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.447
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019331 0 0 0 0 0 0 0 0 0 0 161 170
2019/20202.691 277 110 111 199 166 413 291 308 191 368 123 134
2020/20211.651 67 165 65 182 102 160 53 195 194 193 162 113
2021/2022810 49 153 31 32 9 46 33 62 34 80 92 189
2022/2023866 125 10 30 63 90 212 7 99 132 21 39 38
2023/2024777 63 20 91 60 57 177 46 50 185 20 8 0
Totale 9.091